ATE314462T1 - Verfahren zur transformation dendritischer zellen und aktivierung von t zellen - Google Patents
Verfahren zur transformation dendritischer zellen und aktivierung von t zellenInfo
- Publication number
- ATE314462T1 ATE314462T1 AT97905877T AT97905877T ATE314462T1 AT E314462 T1 ATE314462 T1 AT E314462T1 AT 97905877 T AT97905877 T AT 97905877T AT 97905877 T AT97905877 T AT 97905877T AT E314462 T1 ATE314462 T1 AT E314462T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- cell
- activation
- dendritic
- transforming
- Prior art date
Links
- 210000001744 T-lymphocyte Anatomy 0.000 title abstract 4
- 230000004913 activation Effects 0.000 title abstract 2
- 230000001131 transforming effect Effects 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 5
- 210000000130 stem cell Anatomy 0.000 abstract 2
- 102100036242 HLA class II histocompatibility antigen, DQ alpha 2 chain Human genes 0.000 abstract 1
- 101000930801 Homo sapiens HLA class II histocompatibility antigen, DQ alpha 2 chain Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000001668 ameliorated effect Effects 0.000 abstract 1
- 210000000612 antigen-presenting cell Anatomy 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1143396P | 1996-02-08 | 1996-02-08 | |
PCT/US1997/002063 WO1997029183A2 (en) | 1996-02-08 | 1997-02-07 | Methods and compositions for transforming dendritic cells and activating t cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE314462T1 true ATE314462T1 (de) | 2006-01-15 |
Family
ID=21750351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97905877T ATE314462T1 (de) | 1996-02-08 | 1997-02-07 | Verfahren zur transformation dendritischer zellen und aktivierung von t zellen |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0879281B1 (de) |
JP (1) | JP2000505650A (de) |
AT (1) | ATE314462T1 (de) |
AU (1) | AU730537B2 (de) |
CA (1) | CA2245170A1 (de) |
DE (1) | DE69734974D1 (de) |
WO (1) | WO1997029183A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2227065A1 (en) * | 1995-07-21 | 1997-02-06 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
AU3456099A (en) | 1998-03-31 | 1999-10-18 | Geron Corporation | Methods and compositions for eliciting an immune response to a telomerase antigen |
US7351546B2 (en) | 1998-09-22 | 2008-04-01 | Becton, Dickinson And Company | Flow cytometric, whole blood dendritic cell immune function assay |
US6495333B1 (en) | 1998-09-22 | 2002-12-17 | Becton Dickinson And Company | Flow cytometric, whole blood dendritic cell immune function assay |
CA2367692A1 (en) * | 1999-03-15 | 2000-09-21 | Introgen Therapeutics, Inc. | Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses |
EP1046911A1 (de) * | 1999-04-23 | 2000-10-25 | Universiteit van Amsterdam | Methoden zur Identifizierung von Substanzen, die zelluläre Reaktionen auslösen können |
EP1185627A2 (de) * | 1999-06-01 | 2002-03-13 | Cornell Research Foundation, Inc. | Aktivierung von dendritischen zellen zur verstärkung der immunität |
FR2795415B1 (fr) * | 1999-06-28 | 2003-09-05 | Roussy Inst Gustave | Compose peptidique derive d'une orf decalee du gene ice |
CA2309313A1 (en) * | 1999-08-05 | 2001-02-05 | Board Of Trustees Of The University Of Arkansas | Stimulation of the immune response by human dendritic cell manipulation |
DK1224264T3 (da) * | 1999-10-15 | 2010-05-10 | Baylor Res Inst | Anvendelse af allogene cellelinjer til at belaste antigenpræsenterende celler til at fremkomme med immunresponser |
AU2002306766A1 (en) * | 2001-03-16 | 2002-10-03 | Johns Hopkins University School Of Medicine | Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules |
FR2824567B1 (fr) | 2001-05-11 | 2003-08-08 | Inst Nat Sante Rech Med | Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene |
EP1450828B1 (de) * | 2001-08-17 | 2015-04-01 | Roger Williams Hospital | In situ-immunisierung |
US7955845B2 (en) | 2001-11-20 | 2011-06-07 | Dana Farber Cancer Institute, Inc. | Modified antigen-presenting cells |
US7498171B2 (en) | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
WO2006124700A2 (en) | 2005-05-12 | 2006-11-23 | Introgen Therapeutics, Inc. | P53 vaccines for the treatment of cancers |
US20110313229A1 (en) * | 2008-07-24 | 2011-12-22 | Kiminobu Sugaya | Therapy Targeting Cancer Stem Cells |
EP3376225A1 (de) * | 2010-08-06 | 2018-09-19 | Ludwig-Maximilians-Universität München | Identifizierung von t-zell-zielantigenen |
EP3295945A1 (de) * | 2012-03-13 | 2018-03-21 | HLI Cellular Therapeutics, LLC | Modifizierte erythrozytenvorläuferzellen und verwendungen davon |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
KR950700403A (ko) * | 1992-03-04 | 1995-01-16 | 죤 제이. 쉬바르츠 | 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering) |
EP0563485A1 (de) * | 1992-03-30 | 1993-10-06 | Schering-Plough | In-vitro-Erzeugung von menschlichen dendritischen Zellen |
JPH09500013A (ja) * | 1993-06-01 | 1997-01-07 | ライフ・テクノロジーズ・インコーポレイテッド | カチオン性脂質による遺伝子免疫 |
FR2709309B1 (fr) * | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Compositions cellulaires, préparation et utilisations thérapeutiques. |
JP3957746B2 (ja) * | 1994-06-15 | 2007-08-15 | ノバルティス アクチエンゲゼルシャフト | 骨髄始原細胞および/またはリンパ系始原細胞について富化される細胞集団、ならびに製造方法および使用方法 |
CA2227065A1 (en) * | 1995-07-21 | 1997-02-06 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
-
1997
- 1997-02-07 JP JP9528715A patent/JP2000505650A/ja not_active Ceased
- 1997-02-07 AT AT97905877T patent/ATE314462T1/de not_active IP Right Cessation
- 1997-02-07 AU AU22660/97A patent/AU730537B2/en not_active Ceased
- 1997-02-07 DE DE69734974T patent/DE69734974D1/de not_active Expired - Lifetime
- 1997-02-07 EP EP97905877A patent/EP0879281B1/de not_active Expired - Lifetime
- 1997-02-07 WO PCT/US1997/002063 patent/WO1997029183A2/en active IP Right Grant
- 1997-02-07 CA CA002245170A patent/CA2245170A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0879281B1 (de) | 2005-12-28 |
AU2266097A (en) | 1997-08-28 |
CA2245170A1 (en) | 1997-08-14 |
WO1997029183A3 (en) | 1997-12-18 |
AU730537B2 (en) | 2001-03-08 |
DE69734974D1 (de) | 2006-02-02 |
JP2000505650A (ja) | 2000-05-16 |
WO1997029183A2 (en) | 1997-08-14 |
EP0879281A2 (de) | 1998-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE314462T1 (de) | Verfahren zur transformation dendritischer zellen und aktivierung von t zellen | |
DE69111440D1 (de) | Methoden und zusammensetzungen zur impfung gegen hiv. | |
NL300307I1 (nl) | Werkwijzen voor de replicatie van influenzavirussen in celkweek en de influenzavirussen die verkrijgbaar zijn met behulp van de werkwijze | |
DE60224291D1 (de) | System zur antikörperexpression und- synthese | |
EP1194164B8 (de) | Prion protein peptide und deren verwendung | |
DE69638162D1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
ES2113088T3 (es) | Metodo de entrega de agentes a celulas diana. | |
ATE404587T1 (de) | Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen | |
BRPI0409879A (pt) | composições e métodos para imunoterapia especìfica wt1 | |
ES2185705T3 (es) | Proteina bifuncional, preparacion y uso. | |
DE69609188D1 (de) | Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus | |
GB2428042A (en) | P gingivalis vaccine | |
WO1999016791A3 (en) | Compounds and methods for regulating cell adhesion | |
AR022236A1 (es) | Citoquinas mamiferas purificadas; reactivos y metodos relacionados | |
EP0350690A3 (de) | Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente | |
WO1999036568A3 (de) | Verfahren zum identifizieren von t-zell-stimulierenden proteinfragmenten | |
GB2355983A (en) | Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means | |
AU1060397A (en) | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein | |
WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
BR9713450A (pt) | Quimiocinas de mamìfero | |
WO2002068475A3 (es) | Composicion farmaceutica de fragmentos f(ab)2 de anticuerpos y un proceso para su preparacion | |
EP1986011A3 (de) | Durch eine CD4+-T-Lymphozyten fördernde Krankheit erkannte Peptidepitope | |
WO2003089651A3 (en) | Assay for quantitating secreted antibodies in lymphocytes supernatant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |